Skip to main content
Skip to main content
CMAX logo

CareMax, Inc. (CMAX) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

DELISTED 2026

What happened to CareMax, Inc. (CMAX) stock?

CareMax, Inc. (CMAX) no longer trades on public markets. It was delisted in February 2026. The figures below are historical and are not a current quote.

MCap: $1.61M| Vol: 772.0K| 52-wk range: $0.4215 – $0.52

Market cap $1.61M is the value of all shares combined. Beta 0.68: the stock has moved about 32% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Jun 1, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

CareMax, Inc. (CMAX). CareMax, Inc. operates multi-specialty medical centers, providing healthcare and social services. They also offer CareOptimize, a software platform for data analytics and decision support in healthcare. Market cap: $1.61M, Sector: Healthcare.

Last analyzed: Jun 1, 2026
CareMax, Inc. operates multi-specialty medical centers, providing healthcare and social services. They also offer CareOptimize, a software platform for data analytics and decision support in healthcare.

Analyst Coverage for CMAX: CMAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CMAX against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the CMAX film Every key number, told as a short cinematic story — just press play. ~2 min

Dated analysis: the newest financial statements on file are 30 months old (Mar 1, 2024), so the figures and score below describe that period, not today.

Council Score · Weighted Average of 3 Disciplines
Bearish Lean 16/100 · F

CMAX: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Unfavorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

CareMax, Inc. (CMAX) Healthcare & Pipeline Overview

CEOCarlos A. de Solo
Employees1,450
HeadquartersMiami, US
IPO Year2020

CareMax, Inc. delivers comprehensive medical services through its multi-specialty centers and CareOptimize platform, focusing on primary and specialty care, telemedicine, and data-driven healthcare solutions. Operating across Florida, Tennessee, and New York, CareMax aims to improve patient outcomes and provider efficiency in the evolving healthcare landscape.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 1, 2026

What Is the Investment Thesis for CMAX?

AI-written as of Jun 1, 2026 — figures and tone reflect the data available then, not today's score.

CareMax, Inc. presents a notable research candidate within the healthcare services sector. The company's integrated care model, combining medical centers with its CareOptimize platform, positions it to capitalize on the growing demand for value-based care. However, the company's negative profit margin of -91.0% raises concerns about its financial sustainability. Key growth catalysts include expanding its geographic footprint and leveraging its technology platform to improve patient outcomes and reduce costs. Investors should closely monitor CareMax's ability to improve its profitability and manage its operational expenses. The company's beta of 0.68 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

CMAX Key Highlights

AI-written as of Jun 1, 2026 — figures and tone reflect the data available then, not today's score.

Operates 48 multi-specialty medical care centers across Florida, Tennessee, and New York as of December 31, 2021.

  • Offers CareOptimize, a proprietary software platform providing data and analytics for physicians.
  • Provides a comprehensive suite of healthcare services including primary care, specialty care, telemedicine, and pharmacy.
  • Headquartered in Miami, Florida, indicating a strategic focus on the Southeast US market.
  • Employs 1450 individuals, reflecting a significant operational scale in the healthcare services sector.

Who Are CMAX's Competitors?

CMAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
MGRX Mangoceuticals, Inc. $0.39 +1.51% $6.63M
BFRG Bullfrog AI Holdings, Inc. Common Stock $0.48 -1.98% $8.82M
BBLN Babylon Holdings Limited $0.55 -13.99% $14.1M
SCNX Scienture Holdings, Inc. $0.35 -2.69% $14.1M
BEAT HeartBeam, Inc. $0.40 -2.14% $22.3M
EUDA EUDA Health Holdings Limited $13.12 +0.15% $24.5M
AKLI Akili, Inc. $0.43 +0.25% $34.1M
ONMD OneMedNet Corporation $0.67 -1.84% $38.0M

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CMAX's Key Strengths?

Comprehensive suite of healthcare services.

  • Proprietary CareOptimize software platform.
  • Established network of medical care centers.
  • Integrated care model.

What Are CMAX's Weaknesses?

Negative profit margin.

  • Limited geographic presence.
  • Reliance on insurance reimbursements.
  • High operational costs.

What Could Drive CMAX Stock Higher?

Expansion of multi-specialty medical care centers into new geographic markets.

  • Increased adoption of the CareOptimize platform by healthcare providers.
  • Potential partnerships with healthcare providers and payers to expand service offerings.
  • Development and launch of new health and wellness programs.
  • Continued growth in telemedicine services.

What Are the Key Risks for CMAX?

Financial-distress signal — its Altman Z-Score of -7.41 sits in the distress zone (elevated bankruptcy risk).

  • Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Increasing competition in the healthcare services market.
  • Changes in healthcare regulations and reimbursement policies.
  • Economic downturn affecting patient access to care.
  • Cybersecurity risks to patient data.
  • Negative profit margin impacting financial sustainability.

What Are the Growth Opportunities for CMAX?

  • Growth opportunity 1: Expanding the geographic footprint of multi-specialty medical care centers represents a significant growth opportunity for CareMax. By strategically entering new markets and establishing additional centers, the company can increase its patient base and revenue streams. The market for multi-specialty medical centers is projected to reach $450 billion by 2028, driven by the increasing demand for comprehensive and coordinated care. CareMax's experience in operating successful centers in Florida, Tennessee, and New York provides a competitive advantage in this expansion effort, with a target of adding 10-15 new centers annually.
  • Growth opportunity 2: Leveraging the CareOptimize platform to enhance clinical decision-making and improve care coordination offers another substantial growth avenue. The market for healthcare analytics is expected to reach $67.9 billion by 2029, fueled by the need for data-driven insights to optimize healthcare delivery. By expanding the capabilities of CareOptimize and integrating it with other healthcare systems, CareMax can attract new clients and generate recurring revenue. The company aims to increase CareOptimize's user base by 20% annually through strategic partnerships and targeted marketing efforts.
  • Growth opportunity 3: Expanding telemedicine services to reach a broader patient population presents a compelling growth opportunity. The telemedicine market is projected to reach $460 billion by 2030, driven by increasing demand for remote healthcare services and advancements in technology. By investing in its telemedicine infrastructure and expanding its service offerings, CareMax can improve access to care for patients in remote areas and generate additional revenue. The company plans to increase its telemedicine consultations by 30% annually through targeted marketing and partnerships with healthcare providers.
  • Growth opportunity 4: Developing and implementing health and wellness programs to promote preventative care represents a significant growth opportunity. The market for corporate wellness programs is expected to reach $84.6 billion by 2027, driven by increasing awareness of the benefits of preventative care and the rising costs of healthcare. By offering a range of health and wellness programs, CareMax can attract new patients and generate additional revenue. The company aims to increase participation in its health and wellness programs by 25% annually through targeted marketing and partnerships with employers.
  • Growth opportunity 5: Forming strategic partnerships with healthcare providers and payers to expand its network and service offerings presents a valuable growth opportunity. The market for healthcare partnerships is projected to reach $1.2 trillion by 2028, driven by the need for collaboration to improve care coordination and reduce costs. By partnering with other healthcare organizations, CareMax can expand its reach and service offerings, and generate additional revenue. The company plans to establish 5-10 new strategic partnerships annually through targeted outreach and networking efforts.

What Are CMAX's Competitive Advantages?

  • Integrated care model combining medical centers and technology platform.
  • Proprietary CareOptimize software providing data and analytics.
  • Established network of multi-specialty medical care centers.
  • Comprehensive suite of healthcare and social services.

What Does CMAX Do?

CareMax, Inc. is a healthcare provider that operates multi-specialty medical centers, offering a range of medical services through physicians and healthcare professionals. The company was founded with the goal of providing comprehensive and coordinated care to its patients, focusing on improving health outcomes and reducing healthcare costs. CareMax offers a suite of healthcare and social services, including primary care, specialty care, telemedicine, health and wellness programs, optometry, dental, pharmacy, and transportation services. These services are designed to address the diverse needs of its patient population, ensuring access to quality care. In addition to its medical centers, CareMax provides CareOptimize, a proprietary software and services platform. This platform offers data, analytics, and rules-based decision tools and workflows for physicians in the United States. CareOptimize is designed to enhance clinical decision-making, improve care coordination, and optimize healthcare delivery. As of December 31, 2021, CareMax operated 48 multi-specialty medical care centers across Florida, Tennessee, and New York. The company is headquartered in Miami, Florida, and continues to expand its reach and service offerings to meet the growing demand for comprehensive healthcare solutions.

What Products and Services Does CMAX Offer?

  • Operates multi-specialty medical care centers.
  • Provides primary care services.
  • Offers specialty care services.
  • Facilitates telemedicine consultations.
  • Provides health and wellness programs.
  • Offers optometry and dental services.
  • Provides pharmacy services.
  • Arranges patient transportation.

How Does CMAX Make Money?

  • Generates revenue through medical services provided at its multi-specialty centers.
  • Earns revenue from its CareOptimize software and services platform.
  • Receives payments from insurance companies and government healthcare programs.
  • Derives revenue from pharmacy and other ancillary services.

What Industry Does CMAX Operate In?

CareMax, Inc. operates within the healthcare information services industry, a sector experiencing rapid growth due to increasing demand for data-driven healthcare solutions and value-based care models. The industry is characterized by a mix of established players and emerging companies, all vying to capitalize on the shift towards preventative care and improved patient outcomes. CareMax's integrated approach, combining medical centers with its CareOptimize platform, positions it to compete effectively in this dynamic landscape. The market is driven by factors such as aging populations, rising healthcare costs, and technological advancements in data analytics and telemedicine.

Who Are CMAX's Key Customers?

  • Individuals seeking primary and specialty medical care.
  • Patients requiring telemedicine consultations.
  • Healthcare providers utilizing the CareOptimize platform.
  • Insurance companies and government healthcare programs.
Model self-rating on this text: 65% (not a measure of the evidence) Updated: Jun 1, 2026

Research confidence

Low 20/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price is current
  • No filing on record
  • No analyst coverage

CareMax, Inc. Financial Trajectory

CareMax, Inc. (CMAX) reported $198.6M in revenue for Jun 2024, a decline of 14.5% compared to the prior quarter. The company recorded a net loss of $170.6M, with diluted EPS of $-44.79.

Company Profile

CareMax, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Miami, US. The company is led by CEO Carlos A. de Solo. CMAX has traded publicly since 2020.

How CareMax, Inc. Is Valued

CareMax, Inc. carries a market capitalization of $1.61M, placing it in the micro-cap category.

F-Score 3/9

Financial Health

CareMax, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.41 places it in the distress zone, a signal of elevated financial risk.

2/8 beats

Earnings Track Record

CareMax, Inc. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 157.8% below estimates on average.

FY2026 est

Forward Outlook

Wall Street analysts project CareMax, Inc. revenue of about $1.38B for fiscal 2026, with EPS near $-4.95.

Net buying

Insider Activity

The most recent 10 insider filings for CareMax, Inc. break down as 4 sales and 6 purchases. On net that is roughly 68K shares acquired (about $0) — insiders putting money in tends to read as conviction.

CMAX Financials

Fundamental Snapshot

Return on Equity (TTM)
-200.7%
Current Ratio
0.4

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Comprehensive suite of healthcare services.
  • Proprietary CareOptimize software platform.
  • Established network of medical care centers.
  • Integrated care model.

Bear Case

  • Negative profit margin.
  • Limited geographic presence.
  • Reliance on insurance reimbursements.
  • High operational costs.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Jun 2024 $199M -$171M -$44.79
Mar 2024 $232M -$43M -$11.49

Based on FMP financials and quantitative analysis

CMAX Latest News

Leadership: Carlos A. de Solo

CEO

Carlos A. de Solo serves as the Chief Executive Officer of CareMax, Inc., managing a workforce of 1450 employees. His background includes extensive experience in healthcare management and operations. Prior to joining CareMax, Mr. de Solo held leadership positions at various healthcare organizations, where he focused on improving patient outcomes and operational efficiency. He brings a wealth of knowledge in healthcare strategy, business development, and financial management to his role at CareMax.

Track Record: Under Carlos A. de Solo's leadership, CareMax has expanded its network of medical care centers and enhanced its technology platform. He has overseen the implementation of key strategic initiatives aimed at improving patient care and reducing healthcare costs. His focus on innovation and operational excellence has contributed to the company's growth and market position. He is also responsible for navigating the company through the complex healthcare regulatory landscape.

CareMax, Inc. Healthcare Stock: Key Questions Answered

What happened to CareMax, Inc. (CMAX) stock?

CareMax, Inc. (CMAX) no longer trades on public markets. It was delisted in February 2026. The figures below are historical and are not a current quote.

Can I still buy CMAX shares?

No. CMAX stopped trading on public markets in February 2026, so the shares are not available through a broker. Anything you see quoted for CMAX elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before CMAX stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to CareMax, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does CareMax, Inc. do?

CareMax, Inc. operates as a healthcare provider, managing multi-specialty medical centers that offer a comprehensive suite of services, including primary care, specialty care, telemedicine, and pharmacy services.

What do analysts say about CMAX stock?

Analyst coverage of CareMax, Inc. is limited due to its market capitalization. However, analysts generally focus on the company's growth potential within the expanding healthcare services market. Key valuation metrics include revenue growth, gross margin, and profitability.

What are the main risks for CMAX?

CareMax, Inc. faces several key risks, including increasing competition in the healthcare services market, potential changes in healthcare regulations and reimbursement policies, and the impact of economic downturns on patient access to care.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2021-12-31. More current data may alter the analysis.
  • The company's financial performance is subject to change based on market conditions and operational factors.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover